chr20-50082386-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001032288.3(UBE2V1):c.*382C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.326 in 192,996 control chromosomes in the GnomAD database, including 11,781 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.35 ( 10301 hom., cov: 31)
Exomes 𝑓: 0.25 ( 1480 hom. )
Consequence
UBE2V1
NM_001032288.3 3_prime_UTR
NM_001032288.3 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.763
Genes affected
UBE2V1 (HGNC:12494): (ubiquitin conjugating enzyme E2 V1) Ubiquitin-conjugating E2 enzyme variant proteins constitute a distinct subfamily within the E2 protein family. They have sequence similarity to other ubiquitin-conjugating enzymes but lack the conserved cysteine residue that is critical for the catalytic activity of E2s. The protein encoded by this gene is located in the nucleus and can cause transcriptional activation of the human FOS proto-oncogene. It is thought to be involved in the control of differentiation by altering cell cycle behavior. Alternatively spliced transcript variants encoding multiple isoforms have been described for this gene, and multiple pseudogenes of this gene have been identified. Co-transcription of this gene and the neighboring upstream gene generates a rare transcript (Kua-UEV), which encodes a fusion protein comprised of sequence sharing identity with each individual gene product. [provided by RefSeq, Apr 2012]
PEDS1-UBE2V1 (HGNC:33521): (PEDS1-UBE2V1 readthrough) The TMEM189-UEV mRNA is an infrequent but naturally occurring read-through transcript of the neighboring TMEM189 and UBE2V1 genes. Ubiquitin-conjugating E2 enzyme variant proteins constitute a distinct subfamily within the E2 protein family. They have sequence similarity to other ubiquitin-conjugating enzymes but lack the conserved cysteine residue that is critical for the catalytic activity of E2s. The protein produced by this transcript has UEV1 B domains but the protein is localized to the cytoplasm rather than to the nucleus. The significance of this read-through mRNA and the function of its protein product has not yet been determined. [provided by RefSeq, Oct 2010]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.543 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.347 AC: 52639AN: 151772Hom.: 10277 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
52639
AN:
151772
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.250 AC: 10261AN: 41106Hom.: 1480 Cov.: 2 AF XY: 0.259 AC XY: 5877AN XY: 22698 show subpopulations
GnomAD4 exome
AF:
AC:
10261
AN:
41106
Hom.:
Cov.:
2
AF XY:
AC XY:
5877
AN XY:
22698
Gnomad4 AFR exome
AF:
AC:
243
AN:
496
Gnomad4 AMR exome
AF:
AC:
748
AN:
2956
Gnomad4 ASJ exome
AF:
AC:
192
AN:
814
Gnomad4 EAS exome
AF:
AC:
399
AN:
1568
Gnomad4 SAS exome
AF:
AC:
2070
AN:
6390
Gnomad4 FIN exome
AF:
AC:
462
AN:
1980
Gnomad4 NFE exome
AF:
AC:
5606
AN:
24964
Gnomad4 Remaining exome
AF:
AC:
505
AN:
1834
Heterozygous variant carriers
0
376
752
1127
1503
1879
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.347 AC: 52707AN: 151890Hom.: 10301 Cov.: 31 AF XY: 0.345 AC XY: 25574AN XY: 74234 show subpopulations
GnomAD4 genome
AF:
AC:
52707
AN:
151890
Hom.:
Cov.:
31
AF XY:
AC XY:
25574
AN XY:
74234
Gnomad4 AFR
AF:
AC:
0.549132
AN:
0.549132
Gnomad4 AMR
AF:
AC:
0.296318
AN:
0.296318
Gnomad4 ASJ
AF:
AC:
0.297983
AN:
0.297983
Gnomad4 EAS
AF:
AC:
0.279737
AN:
0.279737
Gnomad4 SAS
AF:
AC:
0.335554
AN:
0.335554
Gnomad4 FIN
AF:
AC:
0.256585
AN:
0.256585
Gnomad4 NFE
AF:
AC:
0.2597
AN:
0.2597
Gnomad4 OTH
AF:
AC:
0.333964
AN:
0.333964
Heterozygous variant carriers
0
1625
3250
4876
6501
8126
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
502
1004
1506
2008
2510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1168
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at